Combination therapy with pioglitazone plus metformin or sulfonylurea in patients with Type 2 diabetes - Influence of prior antidiabetic drug regimen

By Rendell M.S.   Glazer N.B.   Ye Z.  

Journal of Diabetes and its Complications, Vol. 17, Iss. 4, 2003-07 ,pp. : 211-217

Elsevier

Access to resources Recommend Favorite

The effect of intra‐abdominal pressure on the generation of 8‐iso prostaglandin F 2α during laparoscopy in rabbits

By de Souza Ângela M.Bentes   Wang Chi Chiu   Chu Ching Yan   Lam Po Mui   Rogers Michael Scott  

Human Reproduction, Vol. 18, Iss. 10, 2003-10 ,pp. : 2181-2188

Oxford University Press

Access to resources Recommend Favorite

A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study

By Nauck M.   Duran S.   Kim D.   Johns D.   Northrup J.   Festa A.   Brodows R.   Trautmann M.  

Diabetologia, Vol. 50, Iss. 2, 2007-02 ,pp. : 259-267

Springer Publishing Company

Access to resources Recommend Favorite

Effect of metformin and sulfonylurea on C-reactive protein level in well-controlled type 2 diabetics with metabolic syndrome

By Akbar Daad  

Endocrine Journal, Vol. 20, Iss. 3, 2003-04 ,pp. : 215-218

Humana Press, Inc

Access to resources Recommend Favorite

Search for genetic determinants of sulfonylurea efficacy in type 2 diabetic patients from China

By Ren Qian   Han Xueyao   Tang Yong   Zhang Xiuying   Zou Xiantong   Cai Xiaoling   Zhang Simin   Zhang Lihua   Li Hechao   Ji Linong  

Diabetologia, Vol. 57, Iss. 4, 2014-04 ,pp. : 746-753

Springer Publishing Company

Access to resources Recommend Favorite